Posted by Michael Wonder on 18 Feb 2021
Viatris launches Hulio (adalimumab biosimilar) in Canada
18 February 2021 - Viatris announced today that Health Canada has approved Hulio, and product is now available in Canada.
Hulio is a biosimilar to AbbVie's Humira (adalimumab). It is licensed from Fujifilm Kyowa Kirin Biologics and approved for all adalimumab indications.
